Quinolinone derivatives as tyrosine kinase inhibitors

Details for Australian Patent Application No. 2001293275 (hide)

Owner Chiron Corporation

Inventors Renhowe, Paul; Jazan, Elisa; McBride, Chris; McCrea, Bill; Taylor, Clarke; Shafer, Cynthia; Machajewski, Tim; Pecchi, Sabina

Agent FB Rice

Pub. Number AU-B-2001293275

PCT Pub. Number WO02/22598

Priority 60232159 11.09.00 US

Filing date 11 September 2001

Wipo publication date 26 March 2002

Acceptance publication date 14 April 2005

International Classifications

C07D 401/04 Heterocyclic compounds containing two or more hetero rings

A61K 031/4704 - 2-Quinolinones, e.g. carbostyril

C07D 409/04 Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 405/04 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

14 April 2005 Application Accepted

  Published as AU-B-2001293275

11 August 2005 Standard Patent Sealed

31 January 2008 Assignment Registered

  Chiron Corporation The patent has been assigned to Novartis Vaccines and Diagnostic Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001293276

2001293274